Access cutting-edge lung cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
To assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET amplification, solid tumors harboring MET fusion, primary CNS tumors harboring MET alterations, solid tumors harboring wild-type MET with overexpression of HGF and MET * efficacy of APL-101 as an add-on therapy to EGFR inhibitor for the treatment of NSCLC harboring EGFR activating mutations and developed acquired resis
Sponsor: Apollomics Inc.
Check if you qualify for this lung cancer clinical trial in Boston, MA
If you're searching for lung cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.